CABINET MÉDECINE GÉNÉRALE NOISET MATHILDE
ActiveSummary
CABINET MÉDECINE GÉNÉRALE NOISET MATHILDE has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €114k and a net result of €34k. Equity is growing by ~31.9% per year across the filed fiscal years. Its solvency ranks better than 48% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
89
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability91▲+3
Solvency85▲+17
Growth52=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €10k at 30 days acceptable
Liquidity ample (current ratio 1.55 against 1.07 in 2024; short-term debt: 32.4% and cash: 37.9% of total assets), and 39.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
60.4%
Return on assets
17.9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
1 d early
2024
7 d early
2023
67 d early
2022
65 d early
2021
63 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€114k▲ 42.1%
2024 · €80k
2021: €43k
2022: €43k
2023: €52k
2024: €80k
2021 → 2025
Total assets
€189k▲ 1.6%
2024 · €186k
2021: €183k
2022: €132k
2023: €147k
2024: €186k
2021 → 2025
Net result
€34k▲ 19.8%
2024 · €28k
2021: €38k
2022: €6
2023: €9k
2024: €28k
2021 → 2025
Working capital
€34k▲ 371%
2024 · €7k
2021: €62k
2022: €34k
2023: €56k
2024: €7k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€43k-€43k=€52k▲ 20.6%€80k▲ 54.2%€114k▲ 42.1%
Operating result€48k-€1k▼ 97.8%€12k▲ 1,074%€37k▲ 204%€43k▲ 16.4%
Net result€38k-€6▼ 100.0%€9k▲ 155,204%€28k▲ 217%€34k▲ 19.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 16% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €189k
Fixed assets
€94k ▲ 28.2%
Current assets
€95k ▼ 15.6%
Equity and liabilities €189k
Equity
€114k ▲ 42.1%
Debt
€75k ▼ 29.2%
Debt's share of the balance-sheet total falls from 56.8% to 39.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€57k▲
2024 · €50k
Cash flow
€47k▲
2024 · €40k
Current ratio
1.55▲
2024 · 1.07
Debt to equity
0.66▼
2024 · 1.32
ROE
29.6%▼
2024 · 35.2%
ROA
17.9%▲
2024 · 15.2%
Interest coverage
238.56▼
2024 · 354.34
Debt ≤ 1 year
€61k▼
2024 · €105k
Debt > 1 year
€14k
Income taxes
€10k▲
2024 · €9k
Staff costs
€350
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 39 lines
Balance sheet
Code20242025
Assets
Total assets20/58€186k€189k▲
Fixed assets21/28€73k€94k▲
Intangible fixed assets21€72k€60k▼
Tangible fixed assets22/27€958€34k▲
Furniture and vehicles24€958€34k▲
Current assets29/58€113k€95k▼
Amounts receivable within one year40/41€10k€23k▲
Trade receivables40€10k€23k▲
Cash at bank and in hand54/58€99k€72k▼
Deferred charges and accrued income490/1€4k€197▼
Equity and liabilities
Total equity and liabilities10/49€186k€189k▲
Equity10/15€80k€114k▲
Contributions10/11€5k€5k=
Profit (loss) carried forward14€75k€109k▲
Amounts payable17/49€105k€75k▼
Amounts payable after more than one year17-€14k
Financial debts170/4-€14k
Amounts payable within one year42/48€105k€61k▼
Current portion of amounts payable after more than one year42-€6k
Trade debts44€2k€112▼
Suppliers440/4€2k€112▼
Taxes, remuneration and social security45€12k€6k▼
Taxes450/3€12k€6k▼
Other amounts payable47/48€92k€49k▼
Income statement
Code20242025
Remuneration, social security and pensions62-€350
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12k€13k▲
Other operating charges640/8€766€1k▲
Gross operating margin9900€50k€58k▲
Operating profit (loss)9901€37k€43k▲
Financial income75/76B€23€513▲
Recurring financial income75€23€513▲
Financial charges65/66B€140€238▲
Recurring financial charges65€140€238▲
Profit (loss) for the period before taxes9903€37k€44k▲
Income taxes67/77€9k€10k▲
Profit (loss) for the period9904€28k€34k▲
Profit (loss) for the period to be appropriated9905€28k€34k▲
Appropriation of the result
Profit (loss) to be appropriated9906€75k€109k▲
Profit (loss) brought forward from the previous period14P€47k€75k▲
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Equity above €100kEq €114k ▲42.1%
5 profitable years in a row build equity to €114k.
24-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
25-05
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
27-05
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Weakest financial yearnet €6 ▼100%
Net result drops to €6, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity quadruplescurrent ratio 24.02
Current ratio from 6.80 to 24.02; short-term debt falls from €11k to €1k.
29-05
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Namur · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Chaussée de Charleroi 885000 NamurGround area
316 m²
Building footprint
71 m²
Volume, LiDAR
800 m³
Parcel 92302G0024/00V000, Wallonia · tallest building 13.1 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
Chaussée de Charleroi 88, 5000 Namur
since 20212.313.342.112
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92302G0024/00V000 | Wallonia | 316 m² | 1 · 71 m² | 13.1 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Bart De Letter, huisarts
BE 0754.661.285
Hamme (Vl.) · Eq €113,947
Dr. Eva Vanthournout, huisarts
BE 1000.027.933
Gent · Eq €114,134
Maison Médicale Passerelle Santé Louvain La Neuve
BE 0678.746.612
Ottignies-Louvain-la-Neuve · Eq €113,668
Dokter JV
BE 1013.413.438
Houthalen-Helchteren · Eq €113,637
Felidae
BE 1003.032.458
Sint-Agatha-Berchem · Eq €113,584
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,354 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded21-01-2021
Fiscal year end31-12
Abbreviation FR
CMGNM
Activities, NACEBEL 2025
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.